Skip to main content

Advertisement

Log in

Drug-Free Chitosan Coated Poly(isobutylcyanoacrylate) Nanoparticles Are Active Against Trichomonas vaginalis and Non-Toxic Towards Pig Vaginal Mucosa

  • Research Paper
  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose

The present work reports a non-conventional therapeutic strategy based on the use of vaginally-applied formulations for the treatment of trichomoniasis due to Trichomonas vaginalis without adding a drug.

Methods

The formulations were based on a thermosensitive pluronic® F127 hydrogel containing mucoadhesive poly(isobutylcyanoacrylate) nanoparticles coated with a mixture of chitosan and thiolated chitosan (75/25 wt%). The nanoparticles were obtained by anionic emulsion polymerization of isobutylcyanoacrylate. The anti-T. vaginalis activity of the formulations was evaluated in vitro.

Results

Chitosan-coated nanoparticles showed a strong anti-T. vaginalis activity at 100 μg/mL independently on the proportion of thiolated chitosan. No anti-T. vaginalis activity was reported neither with chitosan-uncoated poly(isobutylcyanoacrylate) nanoparticles nor with chitosan used as a solution. These results suggest that the anti-T. vaginalis activity was related to poly(isobutylcyanoacrylate) nanoparticles but only when they are coated with chitosan. Histological analysis of ex vivo pig vaginal mucosa in contact with pluronic® F127 hydrogel containing poly(isobutylcyanoacrylate) nanoparticles coated with the mixture chitosan/thiolated chitosan (75/25 wt%) did not reveal any toxicity.

Conclusion

This study demonstrated that poly(isobutylcyanoacrylate) nanoparticles coated with chitosan were active against T. vaginalis without adding a drug. Besides their anti-T. vaginalis activity, the formulations are non-toxic towards pig vaginal mucosa.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Abbreviations

HIV:

Human immunodeficiency virus

IBCA:

Isobutylcyanoacrylate

MTZ:

Metronidazole

Np:

Nanoparticle

PBS:

Phosphate buffer saline

PIBCA:

Poly(isobutylcyanoacrylate)

SVF:

Simulated vaginal fluid

TBA:

Thiol-butylamidine

TYM:

Trypticase-yeast extract-maltose

References

  1. Cotch MF, Pastorek JG, Nugent RP, Hillier SL, Gibbs RS, Martin DH, et al. Trichomonas vaginalis associated with low birth weight and preterm delivery. The vaginal infections and prematurity study group. Sex Transm Dis. 1997;24(6):353–60.

    Article  CAS  PubMed  Google Scholar 

  2. Hardy P, Nell EE, Spence M, Hardy J, Graham D, Rosenbaum R. Prevalence of six sexually transmitted disease agents among pregnant inner-city adolescents and pregnancy outcome. Lancet. 1984;324(8398):333–7.

    Article  Google Scholar 

  3. Minkoff H, Grunebaum AN, Schwarz RH, Feldman J, Cummings M, Crombleholme W, et al. Risk factors for prematurity and premature rupture of membranes: a prospective study of the vaginal flora in pregnancy. Am J Obstet Gynecol. 1984;150(8):965–72.

    Article  CAS  PubMed  Google Scholar 

  4. Laga M, Nzila N, Goeman J. The interrelationship of sexually transmitted diseases and HIV infection: implications for the control of both epidemics in Africa. AIDS. 1991;5:S55–63.

    PubMed  Google Scholar 

  5. Lomax NJ, Estcourt C, Mirakian R. Symptomatic trichomoniasis, metronidazole allergic and pregnant-a management dilemma. Int J STD AIDS. 2004;15:275–6.

    Article  CAS  PubMed  Google Scholar 

  6. Cudmore SL, Delgaty KL, Hayward-McClelland SF, Petrin DP, Garber GE. Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis. Clin Microbiol Rev. 2004;17:783–93.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  7. Conner TH, Stoeckel M, Evrard J, Legator MS. The contribution of metronidazole and two metabolites to the mutagenic activity detected in the urine in treated humans and mice. Cancer Res. 1977;37:629–33.

    CAS  Google Scholar 

  8. Lindmark DG, Muller M. Antitrichomonad action, mutagenicity, and reduction of metronidazole and other nitroimidazoles. Antimicrob Agents Chemother. 1976;10:476–82.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  9. Bravo-Osuna I, Vauthier C, Farabollini A, Palmieri G-F, Ponchel G. Mucoadhesion mechanism of chitosan and thiolated chitosan poly(isobutylcyanoacrylate) core-shell nanoparticles. Biomaterials. 2007;28:2233–43.

    Article  CAS  PubMed  Google Scholar 

  10. Petit B, Bouchemal K, Vauthier C, Djabourov M, Ponchel G. The counterbalanced effect of size and surface properties of chitosan-coated poly(isobutylcyanoacrylate) nanoparticle on mucoadhesion due to pluronic F68 addition. Pharm Res. 2012;29:943–52.

    Article  CAS  PubMed  Google Scholar 

  11. Mazzaferro S, Bouchemal K, Skanji R, Gueutin C, Chacun H, Ponchel G. Intestinal permeation enhancement of docetaxel encapsulated into methyl-b-cyclodextrin/poly(isobutylcyanoacrylate) nanoparticles coated with thiolated chitosan. J Control Release. 2012;162:568–74.

    Article  CAS  PubMed  Google Scholar 

  12. Owen DH, Katz DF. A vaginal fluid stimulant. Contraception. 1999;59:91–5.

    Article  CAS  PubMed  Google Scholar 

  13. Bernkop-Schnürch A, Hornof M, Zoidl T. Thiolated polymers-thiomers: synthesis and in vitro evaluation of chitosan-2-iminothiolane conjugates. Int J Pharm. 2003;260(2):229–37.

    Article  PubMed  Google Scholar 

  14. Bravo-Osuna I, Schmitz T, Bernkop-Schnürch A, Vauthier C, Ponchel G. Elaboration and characterization of thiolated chitosan-coated acrylic nanoparticles. Int J Pharm. 2006;316(1–2):170–5.

    Article  CAS  PubMed  Google Scholar 

  15. Bouchemal K, Agnely F, Koffi A, Ponchel G. A concise analysis of the effect of temperature and propanediol-1,2 on pluronic F127 micellization using isothermal titration microcalorimetry. J Colloid Interface Sci. 2009;338:169–76.

    Article  CAS  PubMed  Google Scholar 

  16. Aka-Any-Grah A, Bouchemal K, Koffi A, Agnely F, Zhang M, Djabourov M, et al. Formulation of mucoadhesive vaginal hydrogels insensitive to dilution with vaginal fluids. Eur J Pharm Biopharm. 2010;76(2):296–303.

    Article  CAS  PubMed  Google Scholar 

  17. Zhang M, Djabourov M, Bourgaux C, Bouchemal K. Nanostructured fluids from pluronic mixtures. Int J Pharm. 2013;454(2):599–610.

    Article  CAS  PubMed  Google Scholar 

  18. Diamond LS. The establishment of various trichomonads of animals and man in axenic cultures. J Parasitol. 1957;43(4):488–90.

    Article  CAS  PubMed  Google Scholar 

  19. Camuzat-Dedenis B, Provot O, Cointeaux L, Perroux V, Berrien J-F, Bories C, et al. Synthesis and in vitro anti-Trichomonas activities of some new dialkylperoxides and 1,2,4-trioxanes. Eur J Med Chem. 2001;36(10):837–42.

    Article  CAS  PubMed  Google Scholar 

  20. Squier CA, Mantz MJ, Schlievert PM, Davis CC. Porcine vagina ex vivo as a model for studying permeability and pathogenesis in mucosa. J Pharm Sci-US. 2008;97(1):9–21.

    Article  CAS  Google Scholar 

  21. Mazzaferro S, Bouchemal K, Vauthier C, Gueutin C, Palmieri G-F, Ponchel G. What are parameters affecting Leu-enkephalin loading and release from poly(isobutylcyanoacrylate) nanoparticles coated with thiolated chitosan? J Drug Del Sci Tech. 2011;21(5):385–93.

    Article  CAS  Google Scholar 

  22. Couvreur P. Polyaklylcyanoacrylates as colloidal drug carrier. CRC Crit Rev Ther Drug Carrier Syst. 1988;5:1–20.

    CAS  Google Scholar 

  23. Costa e Silva Filho F, Elias CA, de Souza W. Further studies on the surface charge of various strains of Trichomonas vaginalis and Trichomonas foetus. Cell Biophys. 1986;8(3):161–76.

    Article  CAS  PubMed  Google Scholar 

  24. Bernkop-Schnürch A, Kast CE, Guggi D. Permeation enhancing polymers in oral delivery of hydrophilic macromolecules: thiomer/GSH systems. J Control Release. 2003;93:95–103.

    Article  PubMed  Google Scholar 

  25. Quraishi MS, Jones NS, Mason J. The rheology of nasal mucus: a review. Clin Otolaryngol Allied Sci. 1998;23:403–13.

    Article  CAS  PubMed  Google Scholar 

  26. Samet JM, Cheng PW. The role of airway mucus in pulmonary toxicology. Environ Health Perspect. 1994;102:89–103.

    Article  PubMed Central  PubMed  Google Scholar 

  27. Chao C-CW, Vergnes J-P, Brown SI. Fractionation and partial characterization of macromolecular components from human ocular mucus. Exp Eye Res. 1983;36:139–50.

    Article  CAS  PubMed  Google Scholar 

  28. Engel E, Guth PH, Nishizaki Y, Kaunitz JD. Barrier function of the gastric mucus gel. Am J Physiol Gastrointest Liver Physiol. 1995;269:G994–9.

    CAS  Google Scholar 

  29. Gipson IK. Mucins of the human endocervix. Front Biosci J Virtual Libr. 2001;6:1245–55.

    Article  Google Scholar 

  30. van Eyk A, van der Bijl P. Porcine vaginal mucosa as an in vitro permeability model for human vaginal mucosa. Int J Pharm. 2005;305:105–11.

    Article  PubMed  Google Scholar 

  31. Mazzaferro S, Bouchemal K, Maksimenko A, Skanji R, Opolon P, Ponchel G. Reduced intestinal toxicity of docetaxel into mucoadhesive nanoparticles, in mouse xenograft model. J Colloid Sci Biotechnol. 2012;1:210–7.

    Article  Google Scholar 

Download references

ACKNOWLEDGMENTS AND DISCLOSURES

This work was supported by grants from Région Ile de France.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kawthar Bouchemal.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pradines, B., Bories, C., Vauthier, C. et al. Drug-Free Chitosan Coated Poly(isobutylcyanoacrylate) Nanoparticles Are Active Against Trichomonas vaginalis and Non-Toxic Towards Pig Vaginal Mucosa. Pharm Res 32, 1229–1236 (2015). https://doi.org/10.1007/s11095-014-1528-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11095-014-1528-7

KEY WORDS

Navigation